TAROPHEN 36 MG

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

下载 资料单张 (PIL)
08-08-2023

有效成分:

METHYLPHENIDATE HYDROCHLORIDE

可用日期:

TARO INTERNATIONAL LTD, ISRAEL

ATC代码:

N06BA04

药物剂型:

TABLETS EXTENDED RELEASE

组成:

METHYLPHENIDATE HYDROCHLORIDE 36 MG

给药途径:

PER OS

处方类型:

Required

厂商:

SUN PHARMACEUTICAL INDUSTRIES, INC,USA

治疗领域:

METHYLPHENIDATE

疗效迹象:

Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

授权日期:

2023-05-08

资料单张

                                Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) – 1986
This medicine is dispensed with a doctor’s prescription only
Tarophen 18 mg
Tarophen 27 mg
Tarophen 36 mg
Tarophen 54 mg
Extended-release tablets
Active ingredient
Each Tarophen 18 mg tablet contains 18 mg methylphenidate
hydrochloride.
Each Tarophen 27 mg tablet contains 27 mg methylphenidate
hydrochloride.
Each Tarophen 36 mg tablet contains 36 mg methylphenidate
hydrochloride.
Each Tarophen 54 mg tablet contains 54 mg methylphenidate
hydrochloride.
Inactive ingredients and allergens in this medicine: see section 6
‘Additional
information’.
Read the entire leaflet carefully before you start using this
medicine.
This leaflet contains concise information about this medicine. If you
have any
further questions, consult your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may
harm them, even if it seems to you that their medical condition is
similar to
yours.
1. What is this medicine intended for?
Tarophen is intended for the treatment of Attention Deficit
Hyperactivity
Disorder (ADHD) in children over the age of 6, adolescents, and adults
up to
the age of 65.
Therapeutic group: central nervous system stimulant.
Tarophen can improve attention and concentration, and reduce
impulsiveness
and hyperactivity in individuals with ADHD. Tarophen should be given
as part
of an ADHD treatment program that may include counseling or other
therapies.
2. Before using this medicine
Do not use this medicine if you or your child:
•
is sensitive (allergic) to the active ingredient (methylphenidate
hydrochloride) or to any of the other ingredients in this medicine
(see
section 6, ‘Additional information’).
•
is very anxious, mentally tense, or agitated (suffers from
restlessness)
•
has an eye problem called glaucoma (increased intraocular pressure)
•
has tics or Tourette's syndrome, or a family history of Tourette's
syndrome. Tics are involuntary repeated movements or sounds.
•
is 
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 阿拉伯文 08-08-2023
资料单张 资料单张 希伯来文 08-08-2023

搜索与此产品相关的警报